Oruka Therapeutics, Inc. Increase (Decrease) in Accounts Payable
Oruka Therapeutics, Inc. (ORKA) reported Increase (Decrease) in Accounts Payable of $209.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2024-08-01
- Oruka Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2024-06-30 was $42.00K.
- Oruka Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2024-03-31 was $167.00K, a 421.88% increase year-over-year.
- Oruka Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2023-12-31 was $40.00K.
- Oruka Therapeutics, Inc. increase (decrease) in accounts payable for the quarter ending 2023-09-30 was $81.00K.
- Oruka Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2023 was $28.00K.
- Oruka Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2022 was -$783.00K.
- Oruka Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2021 was -$411.00K, a 137.33% decline from fiscal 2020.
- Oruka Therapeutics, Inc. increase (decrease) in accounts payable for fiscal 2020 was $1.10M, a 485.64% increase from fiscal 2019.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 114 month | Increase (Decrease) in Accounts Payable 117 month | Increase (Decrease) in Accounts Payable 120 month | Increase (Decrease) in Accounts Payable 123 month | Increase (Decrease) in Accounts Payable 126 month | Increase (Decrease) in Accounts Payable 129 month | Increase (Decrease) in Accounts Payable 132 month | Increase (Decrease) in Accounts Payable 135 month | Increase (Decrease) in Accounts Payable 138 month | Increase (Decrease) in Accounts Payable 141 month | Increase (Decrease) in Accounts Payable 144 month | Increase (Decrease) in Accounts Payable 147 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $209.00K 10-Q · filed 2024-08-01 | $249.00K derived: sum of 3 quarters · filed 2024-08-01 | $330.00K derived: sum of 4 quarters · filed 2024-08-01 | ||||||||||||
| 2024-03-31 | $167.00K 10-Q · filed 2024-04-25 | $207.00K derived: sum of 2 quarters · filed 2024-04-25 | $288.00K derived: sum of 3 quarters · filed 2024-04-25 | $163.00K derived: sum of 4 quarters · filed 2024-08-01 | ||||||||||||
| 2023-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | $121.00K derived: sum of 2 quarters · filed 2024-02-01 | -$4.00K derived: sum of 3 quarters · filed 2024-08-01 | $28.00K 10-K · filed 2024-02-01 | ||||||||||||
| 2023-09-30 | $81.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-18 | -$44.00K derived: sum of 2 quarters · filed 2024-08-01 | -$12.00K 10-Q · filed 2023-10-18 | -$271.00K derived: sum of 4 quarters · filed 2024-08-01 | ||||||||||||
| 2023-06-30 | -$125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$93.00K 10-Q · filed 2024-08-01 | -$352.00K derived: sum of 3 quarters · filed 2024-08-01 | -$869.00K derived: sum of 4 quarters · filed 2024-08-01 | ||||||||||||
| 2023-03-31 | $32.00K 10-Q · filed 2024-04-25 | -$227.00K derived: sum of 2 quarters · filed 2024-04-25 | -$744.00K derived: sum of 3 quarters · filed 2024-04-25 | -$648.00K derived: sum of 4 quarters · filed 2024-04-25 | ||||||||||||
| 2022-12-31 | -$259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | -$776.00K derived: sum of 2 quarters · filed 2024-02-01 | -$680.00K derived: sum of 3 quarters · filed 2024-02-01 | -$783.00K 10-K · filed 2024-02-01 | ||||||||||||
| 2022-09-30 | -$517.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-18 | -$421.00K derived: sum of 2 quarters · filed 2023-10-18 | -$524.00K 10-Q · filed 2023-10-18 | -$530.00K derived: sum of 4 quarters · filed 2023-10-18 | ||||||||||||
| 2022-06-30 | $96.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-21 | -$7.00K 10-Q · filed 2023-07-21 | -$13.00K derived: sum of 3 quarters · filed 2023-07-21 | -$1.08M derived: sum of 4 quarters · filed 2023-07-21 | ||||||||||||
| 2022-03-31 | -$103.00K 10-Q · filed 2023-04-24 | -$109.00K derived: sum of 2 quarters · filed 2023-04-24 | -$1.18M derived: sum of 3 quarters · filed 2023-04-24 | -$570.00K derived: sum of 4 quarters · filed 2023-04-24 | ||||||||||||
| 2021-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | -$1.07M derived: sum of 2 quarters · filed 2023-02-24 | -$467.00K derived: sum of 3 quarters · filed 2023-02-24 | -$411.00K 10-K · filed 2023-02-24 | ||||||||||||
| 2021-09-30 | -$1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$461.00K derived: sum of 2 quarters · filed 2022-10-28 | -$405.00K 10-Q · filed 2022-10-28 | $613.00K derived: sum of 4 quarters · filed 2022-10-28 | ||||||||||||
| 2021-06-30 | $605.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $661.00K 10-Q · filed 2022-08-02 | $1.68M derived: sum of 3 quarters · filed 2022-08-02 | $1.86M derived: sum of 4 quarters · filed 2022-08-02 | ||||||||||||
| 2021-03-31 | $56.00K 10-Q · filed 2022-05-02 | $1.07M derived: sum of 2 quarters · filed 2022-05-02 | $1.26M derived: sum of 3 quarters · filed 2022-05-02 | $1.45M derived: sum of 4 quarters · filed 2022-05-02 | ||||||||||||
| 2020-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $1.20M derived: sum of 2 quarters · filed 2022-03-14 | $1.39M derived: sum of 3 quarters · filed 2022-03-14 | $1.10M 10-K · filed 2022-03-14 | ||||||||||||
| 2020-09-30 | $186.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $376.00K derived: sum of 2 quarters · filed 2021-11-02 | $83.00K 10-Q · filed 2021-11-02 | $366.00K derived: sum of 4 quarters · filed 2021-11-02 | ||||||||||||
| 2020-06-30 | $190.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$103.00K 10-Q · filed 2021-08-04 | $180.00K derived: sum of 3 quarters · filed 2021-08-04 | $98.00K derived: sum of 4 quarters · filed 2021-08-04 | ||||||||||||
| 2020-03-31 | -$293.00K 10-Q · filed 2021-05-11 | -$10.00K derived: sum of 2 quarters · filed 2021-05-11 | -$92.00K derived: sum of 3 quarters · filed 2021-05-11 | -$103.00K derived: sum of 4 quarters · filed 2021-05-11 | ||||||||||||
| 2019-12-31 | $283.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $201.00K derived: sum of 2 quarters · filed 2021-03-18 | $190.00K derived: sum of 3 quarters · filed 2021-03-18 | $188.00K 10-K · filed 2021-03-18 | ||||||||||||
| 2019-09-30 | -$82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$93.00K derived: sum of 2 quarters · filed 2020-11-02 | -$95.00K 10-Q · filed 2020-11-02 | -$82.00K derived: sum of 4 quarters · filed 2020-11-02 | ||||||||||||
| 2019-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$13.00K 10-Q · filed 2020-08-05 | $0.00 derived: sum of 3 quarters · filed 2020-08-05 | -$188.00K derived: sum of 4 quarters · filed 2020-08-05 | ||||||||||||
| 2019-03-31 | -$2.00K 10-Q · filed 2020-05-06 | $11.00K derived: sum of 2 quarters · filed 2020-05-06 | -$177.00K derived: sum of 3 quarters · filed 2020-05-06 | -$380.00K derived: sum of 4 quarters · filed 2020-05-06 | ||||||||||||
| 2018-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | -$175.00K derived: sum of 2 quarters · filed 2020-02-18 | -$378.00K derived: sum of 3 quarters · filed 2020-02-18 | -$392.00K 10-K · filed 2020-02-18 | ||||||||||||
| 2018-09-30 | -$188.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$391.00K derived: sum of 2 quarters · filed 2019-11-06 | -$405.00K 10-Q · filed 2019-11-06 | -$1.02M derived: sum of 4 quarters · filed 2019-11-06 | ||||||||||||
| 2018-06-30 | -$203.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$217.00K 10-Q · filed 2019-08-01 | -$829.00K derived: sum of 3 quarters · filed 2019-08-01 | -$659.00K derived: sum of 4 quarters · filed 2019-08-01 | ||||||||||||
| 2018-03-31 | -$14.00K 10-Q · filed 2019-05-08 | -$626.00K derived: sum of 2 quarters · filed 2019-05-08 | -$456.00K derived: sum of 3 quarters · filed 2019-05-08 | -$363.00K derived: sum of 4 quarters · filed 2019-05-08 | ||||||||||||
| 2017-12-31 | -$612.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$442.00K derived: sum of 2 quarters · filed 2019-02-27 | -$349.00K derived: sum of 3 quarters · filed 2019-02-27 | -$583.00K 10-K · filed 2019-02-27 | ||||||||||||
| 2017-09-30 | $170.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $263.00K derived: sum of 2 quarters · filed 2018-11-14 | $29.00K 10-Q · filed 2018-11-14 | $222.00K derived: sum of 4 quarters · filed 2018-11-14 | ||||||||||||
| 2017-06-30 | $93.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$141.00K 10-Q · filed 2018-08-09 | $52.00K derived: sum of 3 quarters · filed 2018-08-09 | $309.00K derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||
| 2017-03-31 | -$234.00K 10-Q · filed 2018-05-08 | -$41.00K derived: sum of 2 quarters · filed 2018-05-08 | $216.00K derived: sum of 3 quarters · filed 2018-05-08 | $227.00K derived: sum of 4 quarters · filed 2018-05-08 | ||||||||||||
| 2016-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $450.00K derived: sum of 2 quarters · filed 2018-03-22 | $461.00K derived: sum of 3 quarters · filed 2018-03-22 | $841.00K 10-K · filed 2018-03-22 | ||||||||||||
| 2016-09-30 | $257.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $268.00K derived: sum of 2 quarters · filed 2017-11-09 | $648.00K 10-Q · filed 2017-11-09 | $384.00K derived: sum of 4 quarters · filed 2017-11-09 | ||||||||||||
| 2016-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $391.00K 10-Q · filed 2017-08-03 | $127.00K derived: sum of 3 quarters · filed 2017-08-03 | $158.00K derived: sum of 4 quarters · filed 2017-08-03 | ||||||||||||
| 2016-03-31 | $380.00K 10-Q · filed 2017-05-15 | $116.00K derived: sum of 2 quarters · filed 2017-05-15 | $147.00K derived: sum of 3 quarters · filed 2017-05-15 | $93.00K derived: sum of 4 quarters · filed 2017-05-15 | ||||||||||||
| 2015-12-31 | -$264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | -$233.00K derived: sum of 2 quarters · filed 2017-03-21 | -$287.00K derived: sum of 3 quarters · filed 2017-03-21 | -$431.00K 10-K · filed 2017-03-21 | ||||||||||||
| 2015-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$23.00K derived: sum of 2 quarters · filed 2016-11-14 | -$167.00K 10-Q · filed 2016-11-14 | $263.00K derived: sum of 4 quarters · filed 2016-11-14 | ||||||||||||
| 2015-06-30 | -$54.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$198.00K 10-Q · filed 2016-08-09 | $232.00K derived: sum of 3 quarters · filed 2016-08-09 | -$128.00K derived: sum of 4 quarters · filed 2016-08-09 | ||||||||||||
| 2015-03-31 | -$144.00K 10-Q · filed 2016-05-11 | $286.00K derived: sum of 2 quarters · filed 2016-05-11 | -$74.00K derived: sum of 3 quarters · filed 2016-05-11 | $99.00K derived: sum of 4 quarters · filed 2016-05-11 | ||||||||||||
| 2014-12-31 | $430.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | $70.00K derived: sum of 2 quarters · filed 2016-03-17 | $243.00K derived: sum of 3 quarters · filed 2016-03-17 | $198.00K 10-K · filed 2016-03-17 | ||||||||||||
| 2014-09-30 | -$360.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$187.00K derived: sum of 2 quarters · filed 2015-11-12 | -$232.00K 10-Q · filed 2015-11-12 | -$82.00K derived: sum of 4 quarters · filed 2015-11-12 | ||||||||||||
| 2014-06-30 | $173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $128.00K 10-Q · filed 2015-08-11 | $278.00K derived: sum of 3 quarters · filed 2015-08-11 | $338.00K derived: sum of 4 quarters · filed 2015-08-11 | ||||||||||||
| 2014-03-31 | -$45.00K 10-Q · filed 2015-05-12 | $105.00K derived: sum of 2 quarters · filed 2015-05-12 | $165.00K derived: sum of 3 quarters · filed 2015-05-12 | $175.00K derived: sum of 4 quarters · filed 2015-05-12 | -$1.64M 10-Q · filed 2014-05-13 | |||||||||||
| 2013-12-31 | $150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19 | $210.00K derived: sum of 2 quarters · filed 2015-03-19 | $220.00K derived: sum of 3 quarters · filed 2015-03-19 | $532.00K 10-K · filed 2015-03-19 | -$1.59M 10-K · filed 2014-03-20 | |||||||||||
| 2013-09-30 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $70.00K derived: sum of 2 quarters · filed 2014-11-12 | $382.00K 10-Q · filed 2014-11-12 | $328.00K derived: sum of 4 quarters · filed 2014-11-12 | -$1.74M 10-Q · filed 2013-11-13 | |||||||||||
| 2013-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $322.00K 10-Q · filed 2014-08-13 | $268.00K derived: sum of 3 quarters · filed 2014-08-13 | $161.00K derived: sum of 4 quarters · filed 2014-08-13 | -$1.80M 10-Q · filed 2013-08-13 | |||||||||||
| 2013-03-31 | $312.00K 10-Q · filed 2014-05-13 | $258.00K derived: sum of 2 quarters · filed 2014-05-13 | $151.00K derived: sum of 3 quarters · filed 2014-05-13 | $251.00K derived: sum of 4 quarters · filed 2014-05-13 | -$1.81M 10-Q · filed 2013-05-13 | |||||||||||
| 2012-12-31 | -$54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | -$161.00K derived: sum of 2 quarters · filed 2014-03-20 | -$61.00K derived: sum of 3 quarters · filed 2014-03-20 | -$195.00K 10-K · filed 2014-03-20 | -$2.13M 10-K · filed 2013-03-21 | |||||||||||
| 2012-09-30 | -$107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$7.00K derived: sum of 2 quarters · filed 2013-11-13 | -$141.00K 10-Q · filed 2013-11-13 | -$165.00K derived: sum of 4 quarters · filed 2013-11-13 | -$2.07M 10-Q · filed 2012-11-13 | |||||||||||
| 2012-06-30 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$34.00K 10-Q · filed 2013-08-13 | -$58.00K derived: sum of 3 quarters · filed 2013-08-13 | -$291.00K derived: sum of 4 quarters · filed 2013-08-13 | -$1.96M 10-Q · filed 2012-08-13 | |||||||||||
| 2012-03-31 | -$134.00K 10-Q · filed 2013-05-13 | -$158.00K derived: sum of 2 quarters · filed 2013-05-13 | -$391.00K derived: sum of 3 quarters · filed 2013-05-13 | -$585.00K derived: sum of 4 quarters · filed 2013-05-13 | -$2.06M 10-Q · filed 2012-05-14 | |||||||||||
| 2011-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | -$257.00K derived: sum of 2 quarters · filed 2013-03-21 | -$451.00K derived: sum of 3 quarters · filed 2013-03-21 | -$128.00K 10-K · filed 2013-03-21 | -$1.93M 10-K · filed 2012-03-27 | |||||||||||
| 2011-09-30 | -$233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -$427.00K derived: sum of 2 quarters · filed 2012-11-13 | -$104.00K 10-Q · filed 2012-11-13 | $15.00K derived: sum of 4 quarters · filed 2012-11-13 | -$1.91M 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | -$194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | $129.00K 10-Q · filed 2012-08-13 | $248.00K derived: sum of 3 quarters · filed 2012-08-13 | $238.00K derived: sum of 4 quarters · filed 2012-08-13 | -$1.67M 10-Q · filed 2011-08-15 | |||||||||||
| 2011-03-31 | $323.00K 10-Q · filed 2012-05-14 | $442.00K derived: sum of 2 quarters · filed 2012-05-14 | $432.00K derived: sum of 3 quarters · filed 2012-05-14 | |||||||||||||
| 2010-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | $109.00K derived: sum of 2 quarters · filed 2012-03-27 | -$145.00K 10-K · filed 2012-03-27 | |||||||||||||
| 2010-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$264.00K 10-Q · filed 2011-11-14 | ||||||||||||||
| 2010-06-30 | -$254.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |